Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Colinz Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Colinz Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Colinz Laborator - Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) R

    14 Jul 2025, 4:06PM Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider
  • Colinz Laborator has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    12 Jul 2025, 7:02AM As of June 2025, 66.00% is owned by Indian Promoters and 34.00% by Public. <p align=justify> Top five Promoters holding highest number of shares of Co
  • Colinz Laborator - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jul 2025, 6:32PM We are attaching the Certificate received from our RTA M/s Bigshare Services Pvt Ltd under regulation 74(5) for the month of June-25. Kindly take the
  • Colinz Laborator - Declaration Of Non-Applicability Of Reg. 32 Of The SEBI (LODR) Regulations, 2015 (Statement Of Deviation O

    2 Jul 2025, 5:32PM Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015 for (Statement of Deviation for proceeds of Public issue, Right Issue, OIP if any not appli
  • Colinz Laborator - Declaration With Respect To Non-Applicability Of Related Party Transactions Pursuant To Regulations 23(9)

    2 Jul 2025, 5:28PM Pursuant to Regulation 15(2) of SEBI(LODR), Regulation 2015. and other applicable provision as required under SEBI LODR, We are claiming Exemption und
  • Colinz Laborator - Announcement under Regulation 30 (LODR)-Change in Management

    21 May 2025, 6:38PM Please find the attached the Disclosure under Regulation 30 of SEBI(LODR), Regulations,2015 towards Appointment of Additional Director to Mr. Swapnil
  • Colinz Laborator Q4 net profit up 7.14% at Rs 0.15 cr

    16 May 2025, 6:00PM The company reported standalone net profit of Rs 0.15 crore for the quarter ended March 31, 2025 as compared to Rs 0.14 crore in the same period last
  • Colinz Laborator - Integrated Filing (Financial)

    16 May 2025, 5:54PM Pursuant to SEBI Circular dated 31-12-2024 read with BSE circular no 20250102-4 we are submitting herewith our Integrated Filing (Financial) for the Q
  • Colinz Laborator - Board Meeting Outcome for Outcome Of The Board Meeting

    16 May 2025, 5:45PM In terms of provisions of Regulation 30 (read with Part A of Schedule III) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
  • Colinz Laborator - Outcome Of The Board Meeting

    16 May 2025, 5:43PM As per Regulation 30 of SEBI (LODR)Regulation,2015 uploading our Audited Financial Results for the Quarter and Year Ended on 31-03-2025. Kindly tak
  • Colinz Laborator - Board Meeting Intimation for Notice Of Date Of Board Meeting Pursuant To Regulation 29(2) Of SEBI (LODR) R

    7 May 2025, 3:49PM Colinz Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 ,inter alia, to consider

Key fundamentals

Evaluate the intrinsic value of Colinz Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 10.1153 9.5187 8.4126 8.1719 8.2838
Liabilities 10.1153 9.5187 8.4126 8.1719 8.2838
Equity 2.5191 2.5191 2.5191 3.545 3.545
Gross Profit 0.4951 0.5428 0.6089 0.5861 0.1406
Net Profit 0.4966 0.4867 0.4574 0.3393 0.2075
Cash From Operating Activities -1.4536 1.0347 0.4029 0.4671 2.158
NPM(%) 7.6 6.92 6.39 4.86 3.37
Revenue 6.5277 7.0296 7.1549 6.9742 6.1589
Expenses 6.0326 6.4868 6.546 6.3881 6.0183
ROE(%) 5.24 5.13 4.82 3.58 2.19

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Colinz Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 934.10 1.07 30.97 29.26 301.39 0.54
Lotus Eye Hospital and Institute Ltd 76.00 2.45 215.46 106.60 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.76 -0.91 0.00 221.34 -39.50 0.00
Astec Lifesciences Ltd 896.40 -1.42 0.00 100.53 -601.21 0.00

Company Info

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Colinz Laboratories Ltd., was incorporated under the Companies Act,1956, in the year 1986, as a private limited company and obtained certificate of registration No. 41128 of 1986 on 16th October 1986. The Company was later converted into a public limited company and obtained Certificate of Change of name under the Companies Act, 1956 on 5th January 1995, from the Registrar of Companies, Maharashtra. Though the company was incorporated in the year 1986, the activities of production and marketing was started only in the year 1990. The company is listed in Bombay Stock Exchange. The Company is coming under S.M.E. category. The company is manufacturing and marketing various allopathic and Ayurvedic pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals, ointments etc. The company promotes its products in the states of Maharashtra, Karnataka, Andhra Pradesh, Gujarat, Rajasthan, MP, CG and also in West Bengal through its own marketing staff.

Read More

Parent Organisation

Colinz Laboratories Ltd.

Founded

06/10/1986

Managing Director

NSE Symbol

FAQ

The current price of Colinz Laboratories Ltd is

The 52-week high for Colinz Laboratories Ltd is

The market capitalization of Colinz Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Colinz Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Colinz Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Colinz Laboratories Ltd shares.

The CEO of Colinz Laboratories Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT